potassium citrate
potassium citrate is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including POTASSIUM CITRATE, UROCIT-K, Potassium Citrate. Available dosage forms: tablet, extended release, tablet.
Drug Details
- Generic Name
- potassium citrate
- Brand Names
- POTASSIUM CITRATE, UROCIT-K, Potassium Citrate
- Application Number
- ANDA077440
- Sponsor
- Rising Pharma Holdings, Inc.
- NDC Codes
- 12
- Dosage Forms
- TABLET, EXTENDED RELEASE, TABLET
- Routes
- ORAL
- Active Ingredients
- POTASSIUM CITRATE
Indications and Usage
1 INDICATIONS AND USAGE Potassium Citrate Extended-Release Tablets are a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones ( 1.1 ) Hypocitraturic calcium oxalate nephrolithiasis of any etiology ( 1.2 ) Uric acid lithiasis with or without calcium stones ( 1.3 ) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies ( 14.1 )] . 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies ( 14.2 )] . 1.3 Uric Acid Lithiasis with or without Calcium Stones Potassium citrate is indicated for the management of uric acid lithiasis with or without calcium stones [see Clinical Studies ( 14.3 )] .